Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole XR vs IR in Restless Legs Syndrome
NCT00314860Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2006
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of ropinirole in restless legs syndrome (RLS), sponsored by GSK. Started Feb 2006; status: completed.
02
Drugs
ropinirole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00314860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314860.